trial

Microglia Activation in Schizophrenia

NCTId NCT00205608
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 1 · Completed
Enrollment 20 (estimated)
Sponsored by Amsterdam UMC, location VUmc
Primary completion 2007-03
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 1
Status
Completed
Enrollment
20 (estimated)
Study type
Interventional
Allocation
Non Randomized
Model
Single Group
Masking
None
Start
2004-01
Primary completion
2007-03
Eligibility
ALL · 18 Years · 40 Years

Interventions & indications

Drugs
Positron Emission Tomography

Sponsors

Amsterdam UMC, location VUmcLead Sponsor
UMC UtrechtCollaborator

Investigators

1
Bart van Berckel, MD; PhDPrincipal Investigator

Sites

1 total
Amsterdam, Netherlands

Facts & assertions

4 sourced
Enrollment
20
Phase
PHASE1
Primary Completion Date
2007-03
Status
COMPLETED
relationships
The graph out of here
drug
Positron Emission Tomography
drug
lead_sponsor
Amsterdam UMC, location VUmc
company
collaborator
UMC Utrecht
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Bart van Berckel, MD; PhD
person